BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC • US09624H2085

71.135 USD
+0.95 (+1.36%)
Last: Feb 25, 2026, 09:30 AM
Fundamental Rating

4

BXC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Trading Companies & Distributors industry. BXC has only an average score on both its financial health and profitability. BXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BXC was profitable.
  • BXC had a positive operating cash flow in the past year.
  • BXC had positive earnings in 4 of the past 5 years.
  • BXC had a positive operating cash flow in 4 of the past 5 years.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

  • BXC has a Return On Assets of 0.89%. This is in the lower half of the industry: BXC underperforms 62.00% of its industry peers.
  • With a Return On Equity value of 2.25%, BXC is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
  • BXC has a Return On Invested Capital of 2.26%. This is in the lower half of the industry: BXC underperforms 66.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BXC is above the industry average of 9.42%.
  • The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(2.26%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROIC 2.26%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • BXC's Profit Margin of 0.48% is on the low side compared to the rest of the industry. BXC is outperformed by 62.00% of its industry peers.
  • In the last couple of years the Profit Margin of BXC has declined.
  • Looking at the Operating Margin, with a value of 1.53%, BXC is doing worse than 68.00% of the companies in the same industry.
  • BXC's Operating Margin has improved in the last couple of years.
  • BXC has a Gross Margin of 15.34%. This is amonst the worse of the industry: BXC underperforms 84.00% of its industry peers.
  • In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

  • BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • BXC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.43 indicates that BXC is not in any danger for bankruptcy at the moment.
  • BXC's Altman-Z score of 3.43 is in line compared to the rest of the industry. BXC outperforms 60.00% of its industry peers.
  • A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
  • BXC's Debt to Equity ratio of 0.96 is in line compared to the rest of the industry. BXC outperforms 44.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.43
ROIC/WACC0.24
WACC9.21%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.60 indicates that BXC has no problem at all paying its short term obligations.
  • The Current ratio of BXC (4.60) is better than 90.00% of its industry peers.
  • BXC has a Quick Ratio of 3.15. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • BXC's Quick ratio of 3.15 is amongst the best of the industry. BXC outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 3.15
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • Measured over the past years, BXC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.32% on average per year.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 78.14% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y99.87%
EPS Next 2Y78.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.06%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

  • BXC is valuated quite expensively with a Price/Earnings ratio of 74.88.
  • BXC's Price/Earnings ratio is a bit more expensive when compared to the industry. BXC is more expensive than 66.00% of the companies in the same industry.
  • BXC is valuated expensively when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 37.46, BXC can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, BXC is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. BXC is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 74.88
Fwd PE 37.46
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 80.00% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.87
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • BXC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BXC's earnings are expected to grow with 78.14% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y78.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BLUELINX HOLDINGS INC

NYSE:BXC (2/25/2026, 9:30:26 AM)

71.135

+0.95 (+1.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners99.25%
Inst Owner Change1.67%
Ins Owners2.22%
Ins Owner Change0.01%
Market Cap559.83M
Revenue(TTM)N/A
Net Income(TTM)14.04M
Analysts77.5
Price Target78.03 (9.69%)
Short Float %6.87%
Short Ratio5.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.92%
Min EPS beat(2)-24.67%
Max EPS beat(2)-23.18%
EPS beat(4)2
Avg EPS beat(4)-7.71%
Min EPS beat(4)-24.67%
Max EPS beat(4)16.15%
EPS beat(8)5
Avg EPS beat(8)19.7%
EPS beat(12)7
Avg EPS beat(12)12.15%
EPS beat(16)11
Avg EPS beat(16)19.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.77%
Revenue beat(12)2
Avg Revenue beat(12)-3.86%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 74.88
Fwd PE 37.46
P/S 0.19
P/FCF N/A
P/OCF 33.53
P/B 0.9
P/tB 1.03
EV/EBITDA 8.87
EPS(TTM)0.95
EY1.34%
EPS(NY)1.9
Fwd EY2.67%
FCF(TTM)-3.19
FCFYN/A
OCF(TTM)2.12
OCFY2.98%
SpS374.69
BVpS79.16
TBVpS69.08
PEG (NY)0.75
PEG (5Y)N/A
Graham Number41.14
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROCE 3.36%
ROIC 2.26%
ROICexc 3.32%
ROICexgc 3.63%
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexgc growth 3Y-37.08%
ROICexgc growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score6
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 7.16
Cap/Depr 108.51%
Cap/Sales 1.42%
Interest Coverage 0.97
Cash Conversion 19.98%
Profit Quality N/A
Current Ratio 4.6
Quick Ratio 3.15
Altman-Z 3.43
F-Score6
WACC9.21%
ROIC/WACC0.24
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y99.87%
EPS Next 2Y78.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.73%
Revenue Next Year3.06%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.32%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-8.46%
EBIT Next 3Y8.68%
EBIT Next 5YN/A
FCF growth 1Y-107.18%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.66%
OCF growth 3Y-16.25%
OCF growth 5YN/A

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 1 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 4 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.